Vaccine represents one of the most attractive and fast growing sectors, with players’ revenue exceeding their expectations. The global vaccine market is primarily divided into adult and pediatric segments, further classified into several other sub-segments. Both the adult and pediatric vaccine sectors have sustained the growth momentum and industry participants have been devising strategies to enlarge their presence in these segments.
According to our new research report, “Global Vaccine Market Forecast to 2013”, the global vaccine market is likely to reach an amount worth to US$ 27.6 Billion by the end of 2011, on the back of key factors, such as high growth in emerging markets, technological advancements, strong support from government, and other active associations like WHO and GAVI and increased investment in research activities. With the successful launch of new vaccines in the coming years for key indications, the market for vaccines may further exhibit good performance and it is estimated that the market will reach to the mark of US$ 33 Billion by 2013.
Our analysis of the global vaccine market illustrates that a large number of players are spending huge amount on the aspect of research and development. This is mainly due to the fact that the successful launch of very first vaccine products for any virus may significantly impact the market share. Currently, the companies are actively participating in the trials of vaccines for cancer, malaria, tuberculosis, HIV/AIDS, among others.
The report “Global Vaccine Market Forecast to 2013”, provides an in-depth analysis of the global vaccine market by focusing on key countries of the world. It investigates the current market trends and analyzes their impact on the overall market performance in a broad way. Moreover, the report identifies all the necessary factors and aspects related to market and represent current industry status with future forecast on vaccine types and countries for 2010-2013. In addition, the description of key players and their recent activities have been provided to showcase an effective and balanced outlook of the global vaccine market.
